IDENTITY
CompoundBPC 157
SubstanceBPC 157 Peptide
Strength5 mg
FormLyophilized Powder Vial
ClassResearch Peptide Compound
PEPTIDE PROFILE
OriginSynthetic Peptide Fragment
Sequence15 Amino Acid Peptide
CategoryExperimental Peptide
Research AreaTissue Repair & Recovery
AdministrationResearch Injectable
PHARMACOLOGY
MechanismPeptide Signaling Activity
Target SystemsAngiogenesis & Repair Pathways
Half-lifeLimited Human Data Available
BioavailabilityRoute Dependent
Research StatusExperimental
STORAGE & PACKAGE
BrandDragon Pharma
Package5 mg Multi-dose Vial
StorageRefrigerated Conditions Recommended
ProtectionProtect From Light
FormLyophilized Peptide Powder
ADMINISTRATION PROFILE
Research FormatPeptide Administration
Common Research Range200 mcg/day Research Protocols
FrequencyDaily Administration In Research Settings
DurationVariable Experimental Periods
ApplicationRecovery Research
USAGE PROFILE
Primary InterestTissue Recovery Research
Sports ApplicationRecovery Support Research
Muscle ResearchRegeneration Pathways
Connective TissueRepair Mechanisms
Clinical ApprovalNot Approved For Human Treatment
RECOVERY PROFILE
Research FocusHealing Response
Soft TissueExperimental Evaluation
InflammationResearch Interest
Training RecoveryAthletic Research Application
Evidence LevelPreclinical Research
COMPATIBILITY
Peptide CombinationsResearch Dependent
Recovery ResearchExperimental Protocols
NutritionSupports General Recovery Strategies
TrainingPerformance Recovery Research
MonitoringScientific Evaluation Required
MECHANISM OF ACTION
Primary ActionPeptide-Mediated Cellular Signaling
AngiogenesisResearch Association
Repair PathwaysExperimental Modulation
Growth FactorsPotential Signaling Interaction
Biological RoleInvestigational Regenerative Activity
PHARMACOKINETICS
AbsorptionRoute Dependent
DistributionPeptide-Based Distribution
MetabolismProteolytic Breakdown
ClearanceLimited Human Pharmacokinetic Data
StabilityStorage Sensitive Peptide
SAFETY PROFILE
Human ApprovalNot FDA Approved
Clinical DataLimited Human Evidence
Long-Term SafetyNot Established
Immune ResponsePossible Peptide Sensitivity
MonitoringScientific Supervision Recommended
CONTRAINDICATIONS
PregnancyInsufficient Safety Data
Medical ConditionsProfessional Evaluation Required
AllergyAvoid If Peptide Sensitivity Exists
Chronic DiseaseMedical Assessment Recommended
Research StatusExperimental Compound
CHEMICAL PROFILE
NameBPC 157
TypePentadecapeptide
Amino Acids15 Residues
Molecular DataResearch Variable
ClassificationExperimental Peptide
OVERVIEW
Dragon Pharma BPC 157 5mg contains BPC 157, a synthetic pentadecapeptide studied in preclinical research for its potential relationship with tissue repair mechanisms, angiogenic pathways, gastrointestinal research models and recovery-related biological processes.
POTENTIAL RESEARCH BENEFITS
- Research interest in tissue repair pathways
- Investigated angiogenesis mechanisms
- Studied in gastrointestinal models
- Potential connective tissue research applications
- Explored for recovery-related signaling
- Preclinical regeneration research value
- Interest within sports recovery research
POTENTIAL RISKS
- Limited human clinical evidence
- Unknown long-term safety profile
- Not approved for medical treatment
- Possible immune reactions
- Insufficient standardized dosing data
- Quality variation between sources
- Regulatory restrictions may apply
PERFORMANCE PROFILE
Inflammation Research
65%
CONCLUSION
Dragon Pharma BPC 157 5mg is an experimental peptide product containing BPC 157, a synthetic pentadecapeptide investigated in laboratory studies for its possible involvement in repair-related biological pathways, vascular signaling, gastrointestinal models and connective tissue research.
Unlike approved pharmaceutical therapies, BPC 157 does not currently have established clinical dosing guidelines, approved therapeutic indications, or comprehensive long-term human safety data. Current knowledge is primarily derived from preclinical investigations and laboratory research.
For athletes and bodybuilding communities, BPC 157 has gained attention because of interest in recovery mechanisms and tissue-related research. However, responsible interpretation requires understanding that experimental peptides should not be considered replacements for approved medical treatments or evidence-based injury management strategies.
DISCLAIMER
This content is provided exclusively for educational and informational purposes. It does not constitute medical advice, treatment recommendations, or endorsement of experimental peptide use. BPC 157 is not approved by regulatory agencies such as the FDA for human therapeutic use. Readers should consult qualified healthcare professionals regarding medical conditions, treatments, and applicable regulations in their jurisdiction.
December 16, 2025
I ran a 4-week BPC 157 cycle at 250mcg daily to support shoulder recovery. Pain decreased and mobility improved significantly within the first week. Product quality is excellent—stable, pure, and effective. Ordering online was smooth, payment secure, and shipping fast. Delivery arrived discreetly and professionally packaged. Prices were fair, and the shop is legit, reliable, and responsive. I will be ordering again for future recovery cycles.